IGC Pharma, Inc. Finite-Lived Patents, Gross
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2025-08-14
- 2025-06-30: Finite-Lived Patents, Gross $530.00K.
- 2025-03-31: Finite-Lived Patents, Gross $530.00K.
- 2017-12-31: Finite-Lived Patents, Gross $299.28K.
- 2017-09-30: Finite-Lived Patents, Gross $181.58K.
| Period end | Finite-Lived Patents, Gross |
|---|---|
| 2025-06-30 | $530.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $530.00K 10-Q · filed 2025-08-14 |
| 2017-12-31 | $299.28K 10-Q · filed 2018-02-20 |
| 2017-09-30 | $181.58K 10-Q · filed 2017-11-17 |
| 2017-06-30 | $130.90K 10-Q · filed 2017-08-18 |
| 2017-03-31 | $0.00 10-Q · filed 2018-02-20 |